These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 3736281)

  • 21. Classification and determination of cerebral biovailability of psychotropic drugs by quantitative "pharmaco-EEG" and psychometric investigations (studies with AX-A411-BS).
    Saletu B; Grünberger J; Linzmayer L
    Int J Clin Pharmacol Biopharm; 1977 Oct; 15(10):449-59. PubMed ID: 21853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 1. EEG mapping, psychometric and tolerability findings.
    Saletu-Zyhlarz GM; Anderer P; Wolzt M; Semlitsch HV; Assandri A; Nessi P; Nannipieri F; Rosini S; Saletu B
    Neuropsychobiology; 2009; 59(2):100-9. PubMed ID: 19365150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On central effects of serotonin re-uptake inhibitors: quantitative EEG and psychometric studies with sertraline and zimelidine.
    Saletu B; Grünberger J; Linzmayer L
    J Neural Transm; 1986; 67(3-4):241-66. PubMed ID: 2949057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clovoxamine and fluvoxamine-2 biogenic amine re-uptake inhibiting antidepressants: quantitative EEG, psychometric and pharmacokinetic studies in man.
    Saletu B; Grünberger J; Rajna P; Karobath M
    J Neural Transm; 1980; 49(1-2):63-86. PubMed ID: 6777458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relation between blood levels and average quantitative EEG and psychometrically assessed pharmacodynamic changes following zotepine].
    Saletu B; Grünberger J; Anderer P; Chwatal K
    Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():45-55. PubMed ID: 1683340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Classification and determination of pharmacodynamics of a new antihypoxidotic drug, vinconate, by pharmaco-EEG and psychometry.
    Saletu B; Grünberger J; Linzmayer L; Wittek R
    Arch Gerontol Geriatr; 1984 Jul; 3(2):127-46. PubMed ID: 6476974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A computer-assisted EEG study on psychotropic properties of antiparkinsonian drugs].
    Suitsu N
    Seishin Shinkeigaku Zasshi; 1992; 94(3):238-62. PubMed ID: 1589555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative pharmacodynamic studies with the novel serotonin uptake-enhancing tianeptine and -inhibiting fluvoxamine utilizing EEG mapping and psychometry.
    Saletu B; Grünberger J; Anderer P; Linzmayer L; Zyhlarz G
    J Neural Transm (Vienna); 1996; 103(1-2):191-216. PubMed ID: 9026373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaco-EEG mapping of diazepam effects using different references and absolute and relative power.
    Yamadera H; Kato M; Ueno T; Tsukahara Y; Okuma T
    Pharmacopsychiatry; 1993 Nov; 26(6):254-8. PubMed ID: 8127930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A quantitative pharmaco-EEG study on psychotropic properties of cerebral metabolic enhancers: comparison between young and elderly healthy volunteers].
    Nobuhara K
    Seishin Shinkeigaku Zasshi; 1993; 95(5):392-416. PubMed ID: 8356168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Classification and assessment of cerebral bioavailability of lopirazepam (D-12524) by quantitative EEG and psychometric analysis.
    Saletu B; Grünberger J; Linzmayer L; Stadler R
    Arzneimittelforschung; 1980; 30(3):513-8. PubMed ID: 6104496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmaco-EEG profile of maroxepine: third example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs.
    Herrmann WM; Schärer E; Wendt G; Delini-Stula A
    Pharmacopsychiatry; 1991 Nov; 24(6):214-24. PubMed ID: 1812498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BMS-181168 for protection of the human brain against hypoxia: double-blind, placebo-controlled EEG mapping studies.
    Saletu B; Schulz H; Herrmann WM; Anderer P; Shrotriya RC; Vanbrabant E
    Pharmacopsychiatry; 1994 Sep; 27(5):189-97. PubMed ID: 7838889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative bioavailability studies with a new mixed-micelles solution of diazepam utilizing radioreceptor assay, psychometry and EEG brain mapping.
    Saletu B; Anderer P; Kinsperger K; Grünberger J; Sieghart W
    Int Clin Psychopharmacol; 1988 Oct; 3(4):287-323. PubMed ID: 3235816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacodynamics of venlafaxine evaluated by EEG brain mapping, psychometry and psychophysiology.
    Saletu B; Grünberger J; Anderer P; Linzmayer L; Semlitsch HV; Magni G
    Br J Clin Pharmacol; 1992 Jun; 33(6):589-601. PubMed ID: 1389931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute and subacute CNS effects of milacemide in elderly people: double-blind, placebo-controlled quantitative EEG and psychometric investigations.
    Saletu B; Grünberger J; Linzmayer L
    Arch Gerontol Geriatr; 1986 Oct; 5(3):165-81. PubMed ID: 3541816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic and -dynamic studies with a new anxiolytic, suriclone, utilizing EEG mapping and psychometry.
    Saletu B; Grünberger J; Linzmayer L; Semlitsch HV; Anderer P; Chwatal K
    Br J Clin Pharmacol; 1994 Feb; 37(2):145-56. PubMed ID: 7910470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: II. Double-blind, placebo-controlled EEG mapping and psychometric studies under hypoxia.
    Saletu B; Grünberger J; Anderer P; Linzmayer L
    Methods Find Exp Clin Pharmacol; 1996; 18(1):67-81. PubMed ID: 8721258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EEG brain mapping and psychometry in age-associated memory impairment after acute and 2-week infusions with the hemoderivative Actovegin: double-blind, placebo-controlled trials.
    Saletu B; Grünberger J; Linzmayer L; Anderer P; Semlitsch HV
    Neuropsychobiology; 1990-1991; 24(3):135-48. PubMed ID: 2135068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a specific benzodiazepine antagonist (RO 15-1788) on cerebral blood flow.
    Forster A; Juge O; Louis M; Nahory A
    Anesth Analg; 1987 Apr; 66(4):309-13. PubMed ID: 3105357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.